ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "tophaceous gout"

  • Abstract Number: 358 • 2019 ACR/ARP Annual Meeting

    Emergency Department Encounters in a Large US Payer Database: Tophaceous versus Non-tophaceous Gout Patients

    Meron Mezgebe1, Megan Francis-Sedlak 1, Brian LaMoreaux 1 and Robert Holt 1, 1Horizon Therapeutics plc, Lake Forest, IL

    Background/Purpose: From 2006 to 2012, gout was the primary indication for ~0.2% of all emergency department visits for adults, as reported in the Nationwide Emergency…
  • Abstract Number: 1183 • 2019 ACR/ARP Annual Meeting

    Gout and Serum Urate Levels Are Associated with Lumbar Spine Monosodium Urate Deposition and Chronic Low Back Pain: A Dual-Energy CT Study

    Michael Toprover1, Anastasia Slobodnick 2, Courtney Pike 3, Cheongeun Oh 4, Claudine Davis 2, Michael Mechlin 5 and Michael H Pillinger 6, 1Rheumatology Division, NYU Langone Health and Rheumatology Section, NY Harbor Health Care System, Department of Veterans Affairs., New York, NY, 2Rheumatology Division, NYU Langone Health, New York, 3Rheumatology Section, NY Harbor VA Healthcare System, New York, 4Biostatistics Department, NYU Langone Health, New York, 5Musculoskeletal Radiology, NYU Langone Health, New York, 6Rheumatology Division, NYU Langone Health and Rheumatology Section, NY Harbor Health Care System, Department of Veterans Affairs., New York

    Background/Purpose: More than 130 cases of gout of the spine have been reported, with presenting symptoms including acute back pain, neuropathy, and spinal compression; diagnosis…
  • Abstract Number: 240 • 2015 ACR/ARHP Annual Meeting

    Volumetric Assessment of Tophaceous Gout

    Ralf G. Thiele1, Laura Coates2 and Darren Tabechian1, 1University of Rochester Medical Center, Rochester, NY, 2Medicine, University of Rochester, Rochester, NY

    Background/Purpose: Ultrasound (US) can identify monosodium urate (MSU) tophi within joints, tendons, bursae and other soft tissues. The ability to readily, quickly and inexpensively assess…
  • Abstract Number: 1224 • 2014 ACR/ARHP Annual Meeting

    Pegloticase for Tophus Debulking: Comparison of Dual Energy Computerized Tomography (DECT), Musculoskeletal Ultrasound (MSK-US) and Topographic Caliper Measurement for Assessing Debulking Rate

    Dodji Modjinou1, Elaine Karis2, Soterios Gyftopoulos3, Jonathan Samuels4, Robert T. Keenan5, Daisy Bang6, Kristen Lee4, Svetlana Krasnokutsky-Samuels7, Daria B. Crittenden8 and Michael H. Pillinger8, 1Internal Medicine/Rheumatology, NYU/HJD, New York, NY, 2pending, pending, NY, 3Radiology, NYU Langone Medical Center/NYU Hospital for Joint Diseases, New York, NY, 4Rheumatology, NYU Langone Medical Center, New York, NY, 5Rheumatology, Duke University, Durham, NC, 6Division of Rheumatology, NYU School of Medicine, New York, NY, 7Rheumatology, NYU School of Medicine, New York, NY, 8NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose: Pegloticase is approved for lowering serum urate (sUA) in chronic refractory tophaceous gout (CRTG), but the rate of tophus resolution is not well defined,…
  • Abstract Number: 118 • 2014 ACR/ARHP Annual Meeting

    Difficult to Treat Gouty Arthritis Associated with Poor Health Related Quality of Life and High Resource Utilization: Post- Hoc Analysis

    Louis Bessette1, Frédéric Lioté2, Carmen Moragues3, Rüdiger Moericke4, Zhang Zhiyi5, Alberto Ferreira6, Pascal Lecomte6, Sophia Kessabi6, Haijun Tian7 and Jasvinder A. Singh8,9, 1CHUL, Quebec, QC, Canada, 2Hôpital Lariboisière & University Paris Diderot, Paris, France, 3Hospital Platón, Barcelona, Italy, 4Institut für Präventive Medizin & Klinische Forschung GbR, Magdeburg, Germany, 5The First Affiliated Hospital of Haerbin Medical University, Haerbin, China, 6Novartis Pharma AG, Basel, Switzerland, 7Novartis Pharmaceuticals Corporation, East Hanover, NJ, 8Mayo Clinic, Rochester, MN, 9University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Difficult-to-treat (DTT) group in the MOTION study included symptomatic refractory gouty arthritis (RGA) patients with ≥3 flares, refractory to NSAIDs/colchicine/steroids or to uric acid…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology